INC Research's initial public offering of common stock is expected to happen next week.
IPOscoop.com's calendar of IPO dates, based on information obtained from underwriters, reports that INC's shares are expected to begin trading on Friday. That means that the company's shares are likely to be priced Thursday after the markets close.
Likewise, Renaissance Capital's IPO calendar also anticipates that INC will go public next week.
The Raleigh pharmaceutical services company disclosed in a Securities and Exchange Commission filing this week that it hopes to generate net proceeds of $135 million, after expenses, by selling 8.1 million shares of stock with a target price between $17 and $20 per share.
INC has about 5,500 employees worldwide, including more than 850 in Raleigh. It's in the business of helping pharmaceutical and biotechnology companies test experimental drugs.
Through the first nine months of this year, INC generated $26.3 million in net income on $596 million in revenue.
INC is one of two Triangle contract research organizations, or CROs, that plan to go public. The other is Raleigh-based PRA Health Sciences.